Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Lung cancer]

K Furuse1

  • 1Dept. of Internal Medicine, National Kinki Central Hospital for Chest Disease, Japan.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|November 14, 1997
PubMed
Summary
This summary is machine-generated.

New chemotherapy drugs show promise for lung cancer treatment, offering unique mechanisms and better toxicity profiles than cisplatin. This review covers agents like paclitaxel and gemcitabine, highlighting their development status.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Histological Examination of Bronchial Mucosa after Photodynamic Therapy Showing no Selectivity of Effect between Tumour and Normal Mucosa.

Lasers in medical science·2014
Same author

Chemotherapy-induced neutropenia as a prognostic factor in advanced non-small-cell lung cancer: results from Japan Multinational Trial Organization LC00-03.

British journal of cancer·2009
Same author

Photon emissions from rice cells elicited by N-acetylchitooligosaccharide are generated through phospholipid signaling in close association with the production of reactive oxygen species.

Plant physiology and biochemistry : PPB·2006
Same author

Critical factors for patient management.

Lung cancer (Amsterdam, Netherlands)·2004
Same author

Consensus: the follow-up of the treated patient.

Lung cancer (Amsterdam, Netherlands)·2004
Same author

[A resected case of malignant fibrous histiocytoma of the chest wall].

Kyobu geka. The Japanese journal of thoracic surgery·2003
Same journal

[A Case of Pulmonary Epithelioid Hemangioendothelioma Associated with Multiple Cancers].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Long-Term Survival in Three Cases with Pulmonary Metastases from Colorectal Cancer Given Low-Dose S-1 Under a Regimen Combining a Carbohydrate-Restricted Ketogenic Diet, Metformin, Vitamin D, Eicosapentaenoic Acid, and Other Complementary Therapies].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Preventive Effect of Saline Eye Wash for Eye Symptoms Due to High-Dose and Intermediate-Dose Cytarabine Therapy].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Examination of Factors Affecting the Efficacy of Naldemedine Tosilate Tablets for Opioid-Induced Constipation].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Recent Advances in the Treatment of HER2-Altered Solid Tumors].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[BRAF-Mutant Solid Tumor].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
See all related articles

Area of Science:

  • Oncology
  • Pharmacology

Background:

  • Lung cancer remains a leading cause of cancer-related mortality worldwide.
  • Standard chemotherapy, often cisplatin-based, faces challenges with toxicity and resistance.
  • Novel chemotherapeutic agents are under development to improve treatment outcomes.

Purpose of the Study:

  • To review the development status of promising novel chemotherapeutic agents for lung cancer.
  • To evaluate these agents based on mechanism of action, toxicity, single-agent activity, and synergistic potential.
  • To provide an overview of key drugs including paclitaxel, docetaxel, vinorelbine, CPT-11, topotecan, and gemcitabine.

Main Methods:

  • Literature review of recently developed chemotherapeutic agents for lung cancer.
  • Analysis of agent characteristics including mechanism of action and toxicity profiles.

Related Experiment Videos

  • Assessment of single-agent activity (response rate, survival rate) and synergistic effects.

    • Main Results:

    • Several novel agents demonstrate potential for improved lung cancer treatment.
    • These agents aim for unique mechanisms and more favorable toxicity compared to cisplatin.
    • Key drugs reviewed include paclitaxel, docetaxel, vinorelbine, CPT-11, topotecan, and gemcitabine.

    Conclusions:

    • Novel chemotherapeutic agents offer promising alternatives for lung cancer therapy.
    • These agents are being evaluated for their potential to enhance efficacy and reduce toxicity.
    • Further development and clinical trials are crucial to establish their role in lung cancer treatment.